(Q53432944)

14 May 2018

title

The Decline of Pertussis-Specific Antibodies After Tetanus, Diphtheria, and Acellular Pertussis Immunization in Late Pregnancy. (English)

1 reference

14 May 2018

0 references

Bahaa Abu Raya

1 reference

14 May 2018

Isaac Srugo

1 reference

14 May 2018

Aharon Kessel

1 reference

14 May 2018

Michael Peterman

1 reference

14 May 2018

Avraham Vaknin

1 reference

14 May 2018

Ellen Bamberger

1 reference

14 May 2018

language of work or name

English

0 references

publication date

8 June 2015

1 reference

14 May 2018

Journal of Infectious Diseases

published in

1 reference

14 May 2018

volume

212

1 reference

14 May 2018

issue

1 reference

14 May 2018

page(s)

1869-1873

1 reference

14 May 2018

Quantification of vaccine-induced antipertussis toxin secretory IgA antibodies in breast milk: comparison of different vaccination strategies in women

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

The protective role of maternally derived antibodies against Bordetella pertussis in young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV324

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV324

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rg6alggo2vglld36l4mhrxomqq

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_rg6alggo2vglld36l4mhrxomqq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rg6alggo2vglld36l4mhrxomqq

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/rg6alggo2vglld36l4mhrxomqq

1 reference